Todd P Glancy

USPTO Granted Patents = 24 (Patent Applications = 5)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 2)

Average Co-Inventor Count = 5.0

ph-index = 9

Forward Citations = 357(Granted Patents)

Company Filing History:

7 out of 153

Depuy Orthopaedics, Inc.

Corteva Agriscience LLC

patents

5. 2 out of 1,164

Boehringer Mannheim Gmbh

Years Active: 1995-2025

Loading Chart...

24 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12421522 - Modulation of transgene expression in plants (2025-09-23),

2. 12264321 - Cry1D for controlling corn earworm (2025-04-01),

3. 11879129 - Modulation of transgene expression in plants (2024-01-23),

4. 11795471 - Cry1D for controlling corn earworm (2023-10-24),

5. 11485983 - Cry1D for controlling corn earworm (2022-11-01),

6. 11473095 - Modulation of transgene expression in plants (2022-10-18),

7. 10683517 - Cry1D for controlling corn earworm (2020-06-16),

8. 10612036 - Engineered Cry6A insecticidal proteins (2020-04-07),

9. 10570182 - Modified Cry1Ca toxins useful for control of insect pests (2020-02-25),

10. 9890390 - CRY1D for controlling corn earworm (2018-02-13),

11. 9738705 - Monoclonal antibodies specific for Cry1Ca and related detection methods (2017-08-22),

12. 8008466 - Use of untranslated region of osmotin gene to enhance transgene expression in plants (2011-08-30),

13. 8003777 - Use of untranslated region of osmotin gene to enhance transgene expression in plants (2011-08-23),

14. 7122205 - Bioerodable polymeric adhesives for tissue repair (2006-10-17),

15. 6923985 - Bioerodable polymeric adhesives for tissue repair (2005-08-02),

Title: Innovations and Contributions of Todd P. Glancy

Introduction

Todd P. Glancy is an accomplished inventor based in Fairmount, Indiana, known for his significant contributions to the field of agricultural biotechnology. With a remarkable portfolio of 22 patents, Todd has dedicated his career to enhancing crop protection and optimizing plant genetic engineering.

Latest Patents

Among his most recent innovations are the patents concerning the modulation of transgene expression in plants. This patent focuses on the use of endogenous plant RNA interference (RNAi) machinery to specifically reduce transgene expression, particularly in seed tissues of dicot plants. Another notable invention is related to Cry1D, which plays a crucial role in controlling corn earworm. This patent highlights the discovery that Cry1Da possesses effective activity against the corn earworm, providing methods for using this protein in transgenic plants to guard against significant crop damage. Leaf and silk bioassays demonstrated the efficacy of transgenic maize expressing Cry1Da in protecting against corn earworm larvae.

Career Highlights

Throughout his career, Todd P. Glancy has worked with prominent firms such as DePuy Orthopaedics, Inc. and Dow Agrosciences LLC. His expertise in plant biotechnology and transgenic research has positioned him as a leader in this dynamic field, influencing advancements in agricultural practices.

Collaborations

Collaborating with esteemed colleagues like Dale R. Peterson and Z. David Deng, Todd has made strides in his research endeavors. These partnerships have allowed him to leverage diverse expertise and foster innovation within the agricultural sector.

Conclusion

Todd P. Glancy continues to make valuable contributions to the field of biotechnology with his innovative patents and extensive experience. His work not only protects crops but also supports the advancement of sustainable agricultural practices, ensuring food security for future generations.

This text is generated by artificial intelligence and may not be accurate.